Product Description A groundbreaking prescription for health care reform--from a legendaryleader in innovation . . .Our health care system is in critical condition. Each year, fewer Americans can afford it, fewer businesses can provide it, and fewer government programs can promise it for future generations. We need a cure, and we need it now. Harvard Business School's Clayton M. Christensen whose bestselling The Innovator's Dilemma revolutionized the business world presents The Innovator's Prescription, a comprehensive analysis of the strategies that will improvehealth care and make it affordable. Christensen applies the principles of disruptive innovation to the broken health care system with two pioneers in the field Dr. Jerome Grossman and Dr. Jason Hwang. Together, they examine arange of symptoms and offer proven solutions. YOU LL DISCOVER HOW Precision medicine reduces costs and makes good on the promise of personalized care Disruptive business models improve quality, accessibility, and affordability by changing the way hospitals and doctors work Patient networks enable better treatment of chronic diseases Employers can change the roles they play in health care to compete effectively in the era of globalization Insurance and regulatory reforms stimulate disruption in health care.
A Guide to Unleashing Efficiencies More Rapidly in U.S. HealthcareJuly 28, 2010 Professor Donald Mitchell(Thanks for Providing My Reviews over 96,000 Helpful Votes Globally) 1 out of 1 found this review helpful
"For I know the thoughts that I think toward you, says the LORD, thoughts of peace and not of evil, to give you a future and a hope." -- Jeremiah 29:11 (NKJV)
In The Innovator's Prescription, disruptive innovation expert Professor Clayton M. Christensen teams with Jerome H. Grossman, M.D., and Jason Hwang, M.D. to consider how new technologies, improved business models, changed processes, improved regulation, and better ways of training can greatly expand the amount of health care that can be provided for what is being spent now, opportunities to speed better treatments through development and testing, and patients can be encouraged to do more for themselves. The basic arguments are based on analogies to other major industries where disruptive innovation caused costs to drop as greatly simplification and specialization occurred.
I think that few will disagree that the opportunities described here are mostly real ones. I wasn't convinced that the foundations for change are sufficiently well established to make serious shifts in the United States. I believe that what is described here is very likely to occur rather in the rapidly developing part of the emerging market countries such as India (home of Aravind Eye Care System) where the lack of any health care for many creates a humanitarian incentive to lower regulatory barriers and to push aside old, outmoded habits.
Americans don't seem to be fundamentally unhappy with their system of very expensive health care that produces results in many categories that are inferior to what is achieved in other developed countries. It's a lot like the benefits the U.S. government dispenses when it runs trillion dollar deficits. Most people are getting a lot more back than what they put in. The free lunch will have to stop before the efficiencies will begin.
I was pleased to see that unlike earlier books by Professor Christensen this one attempts to integrate business model innovation into the discussion. The result was unfortunately pretty primitive, describing four categories of business models rather than the full richness of business model innovation. I'm increasingly persuaded that the so-called disruptive innovation school is really just the study of how specialists simplify, streamline, and organize markets that poorly organized generalists are trying to milk through charging as high prices as possible. That's only one category of disruptive innovation, but it is certainly a valid one that has been very important for over 100 years.
The book's other missed opportunity is to look well beyond what today's best practices suggest . . . toward what the ideal way to foster competition to do a great deal more for less and improved health (rather than health care) would look like.
Despite those missed opportunities, I don't know of a better book for proposing some helpful ways to at least allow Americans to get more health care for what is being spent. Nice work!
This book should be required reading for U.S. physicians.July 12, 2010 Susan Kay Palmer(EUGENE, OR, US) 1 out of 1 found this review helpful
This book points out how the "incentives" for physicians and hospitals are not aligned in the interests of patients and overall American health. It calls for an abrupt and radical shift in the organization of health care services. The unsustainable current "non system" must change because it does not serve patients very well, and because it is not affordable. American medicine in NOT the "best in the world". American medicine is inventive and has some enviable features. These positives do not excuse physicians from becoming educated about the needed reformation of the delivery of more evidence-based health care services.
Husband pleased with purchaseJuly 5, 2010 A. MacGregor 0 out of 1 found this review helpful
My husband asked me to order this for him and he was very impressed by the speediness of delivery as well as the book living up to his expectations
Must ReadJune 25, 2010 Bob Grable 1 out of 1 found this review helpful
This book is a must read for anyone in the life or health science field. Highly comprehensive and provides great insight into the current health care system and how it could change.
The Innovator's Prescription: A Disruptive Solution for Health CareJune 22, 2010 Jonathan Callund(Santiago) 1 out of 1 found this review helpful
Excellent - a step back from the inertia that's been driving healthcare reform and a timely and refreshing approach.
CERTAIN CONTENT THAT APPEARS ON THIS SITE COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.